The mission of CVPath Institute, Inc. is to provide expert consultative and research services to strengthen public understanding of cardiac and vascular diseases in order to advance the care of patients with such diseases.

The research team at CVPath focuses primarily on the study of atherosclerosis, sudden cardiac death, myocardial ischemia, valvular heart disease, and interventional treatments. The principal goal of the CVPath Institute is to provide histopathology and diagnostic services for clinicians, cardiologists and pathologists seeking to evaluate and improve the efficacy of stents and other interventional cardiovascular devices. It also provides advanced training programs for clinicians who desire advancement in the field of cardiovascular disease.

A major research interest of CVPath is the characterization, imaging, and treatment of fatal atherosclerotic plaques, a leading cause of death in the Western World and, increasingly, in Asia and the third world. The Institute also provides consultative support for the testing of vascular stents aimed at decreasing neointimal growth and restenosis and incidence of late in-stent thrombosis. Additionally, the CVPath Institute studies the development of cell-based therapies intended to reduce the burden of ischemia in heart failure. The medical knowledge gained from various pathologic studies supported by CVPath is instrumental for the transition of new therapies from the laboratory into daily clinical practice.

CVPath seeks grant moneys from federal and non-federal sources to conduct independent research in cardiac and vascular diseases. It also engages in collaborative research with other investigators to design, improve, and evaluate interventional devices as a prelude to clinical studies. Our continued use and development of relevant animal models of human diseases furthers the understanding of atherosclerosis along with the interaction of interventional devices with the heart and related vasculature. These models also yield critical insights into disease processes guiding the development of future therapies.

The Institute is committed to wide dissemination of the knowledge produced by its research via publications in prominent scientific journals and books, as well as presentations at scientific conferences in the United States and abroad. It also makes its findings available to the medical and scientific communities and the general public through reports on the Internet and other news-based services through interviews.